Smoothened (Smo) is essential for transduction of the Hedgehog (Hh) signal in both insects and vertebrates. Cell surface/cilium accumulation of Smo is thought to play an important role in Hh signaling, but how the localization of Smo is controlled remains poorly understood. In this study, we demonstrate that atypical PKC (aPKC) regulates Smo phosphorylation and basolateral accumulation in Drosophila wings. Inactivation of aPKC by either RNAi or a mutation inhibits Smo basolateral accumulation and attenuates Hh target gene expression. In contrast, expression of constitutively active aPKC elevates basolateral accumulation of Smo and promotes Hh signaling. The aPKC-mediated phosphorylation of Smo at Ser680 promotes Ser683 phosphorylation by casein kinase 1 (CK1), and these phosphorylation events elevate Smo activity in vivo. Moreover, aPKC has an additional positive role in Hh signaling by regulating the activity of Cubitus interruptus (Ci) through phosphorylation of the Zn finger DNA-binding domain. Finally, the expression of aPKC is up-regulated by Hh signaling in a Ci-dependent manner. Our findings indicate a direct involvement of aPKC in Hh signaling beyond its role in cell polarity.
aPKC | Ci | Hh | Par6 | Smo H edgehog (Hh) was originally discovered as a segment polarity gene involved in Drosophila embryo development (1) . It has been shown that Hh family members function as morphogens and play critical roles in pattern formation and cell growth control; therefore, aberrant Hh signaling causes birth defects as well as several types of cancer (2) (3) (4) . The Hh signal is transduced by a signaling cascade that is highly conserved among different species. One of the best model systems for studying Hh signal transduction is the Drosophila wing imaginal disc, which is divided into posterior (P) and anterior (A) compartments. The P compartment cells express and secrete Hh proteins that act upon neighboring A compartment cells located adjacent to the A/P boundary to induce the expression of decapentaplegic (dpp) (5, 6) . The Dpp protein then diffuses bidirectionally into both the A and P compartments and functions as a morphogen to control the growth and patterning of cells in the entire wing in a concentrationdependent manner (7) (8) (9) . Hh also activates other genes, including collier (col), patched (ptc), and engrailed (en). Low levels of Hh are able to induce the expression of dpp, whereas higher levels of Hh are also able to activate col and ptc. The induction of en appears to require the highest doses of Hh signaling activities (10, 11) .
Cell polarity is established by a conserved protein complex containing the partition defective (Par) proteins, Bazooka (Baz)/ Par3 and Par6, as well as the atypical PKC (aPKC), all of which have been shown to be essential for the formation of polarized epithelia (12) . Epithelial polarity also depends on polarity complexes containing Crumbs (Crb), which localizes to the apical domain and interacts with aPKC-Par6 in both Drosophila and mammalian epithelia, thereby acting as the apical determinant (13) (14) (15) . In Drosophila embryo, the aPKC-Baz-Par6 apical protein complex functions together with Crb to regulate apical/basal polarity, and this apical complex is antagonized by a basolateral protein complex containing Scribble (Scrib), Discs large (Dlg), and Lethal giant larvae (Lgl) (16, 17) . It is unknown whether there is a genetic or physiological interaction between Hh signaling components and the epithelial polarity complex.
Smoothened (Smo), an atypical G protein-coupled receptor, is essential in both insects and mammals for transduction of the Hh signal. Abnormal Smo activation results in basal cell carcinoma (BCC) and medulloblastoma, so it remains an attractive therapeutic target. In Drosophila, binding of Hh to the receptor complex consisting Ptc and Interference Hedgehog (Ihog) relieves the inhibition of Smo by Ptc (10, 18, 19) , ultimately allowing Smo to activate the Cubitus interruptus (Ci)/Gli family of Zinc finger transcription factors, and thereby induce the expression of Hh target genes, such as dpp, col, ptc, and en (10, 11) . Studies have shown that Hh induces cell surface accumulation and phosphorylation of Smo by multiple kinases, including PKA and casein kinase 1 (CK1), CK2, and G protein-coupled receptor kinase 2 (Gprk2), which activate Smo by inducing differential phosphorylation, and thus the conformational change in the protein (20) (21) (22) (23) (24) (25) (26) . In addition, Smo cell surface accumulation is controlled by endocytic trafficking that is mediated by ubiquitination (27, 28) . In mammals, Hh signal transduction depends on the primary cilium, and ciliary accumulation is required for Smo activation (29) (30) (31) (32) (33) . Therefore, cilium may function as a signaling center for the Hh pathway in mammals (34) . However, the precise mechanism by which Smo cell surface or ciliary accumulation is regulated remains unclear.
Here (20) , many of which are not linked to the aforementioned kinases, leading to the hypothesis that additional kinase(s) may be involved in Smo phosphorylation and regulation. We screened a partial RNAi library targeting the S/T kinases in the Drosophila genome. Individual RNAi lines from the Vienna Drosophila RNAi Center (VDRC) and Bloomington Stock Center (BSC) were expressed through wing-specific MS1096 Gal4 to determine whether they induced adult wing phenotypes or caused changes in Smo and Ci accumulation in wing discs (the results of the whole screen will be published elsewhere). We found that inactivation of aPKC by aPKC-RNAi 35001 attenuated Hh-induced accumulation of Smo (Fig. 1B) and inhibited the expression of Hh target genes, such as col-lacZ, dpp-lacZ, and ptc-lacZ ( Fig. 1 C-E) . The phenotype of aPKC-RNAi is unlikely due to an off-target effect because expression of two different transgenic RNAi lines (VDRC v105624 and BSC 35001) targeting nonoverlapping regions of an aPKC sequence produced a similar phenotype and expression of either of these lines blocks aPKC expression in wing disc (Fig. 1F) . To examine aPKC gain of function, we overexpressed a membranetethered form of aPKC (aPKC CAAX ) or a constitutively active form of aPKC (aPKC ΔN ) lacking the N-terminal pseudosubstrate regulatory domain and found that gain of function of aPKC promoted Smo accumulation and induced ectopic dpp-lacZ expression and Ci accumulation ( Fig. 1 G and H) . We also used actin>CD2>Gal4 to generate clones that express aPKC CAAX and found aPKC CAAX expression resulted in Smo accumulation (Fig. S1A) .
To examine the physiological function of aPKC in Hh signaling further, we used mitotic recombination to generate clones homozygous for aPKC K06403 , a strong allele of aPKC (35) . We found that in aPKC mutant cells, Smo accumulated in apical membrane of wing disc ( Fig. 2 A and C) , leading to a reduction in basolateral Smo accumulation ( Fig. 2 B and C) . The expression of dpp-lacZ, en, and ptc was blocked in aPKC mutant cells (Fig. 2 B, D , and E). Consistently, inactivation of aPKC by RNAi blocked, whereas the expression of aPKC CAAX increased, basolateral accumulation of Smo (Fig. 2 F-H) . These data suggest that aPKC regulates Hh signal transduction, at least in part, by promoting Smo basolateral accumulation.
aPKC Acts Downstream of Ptc in Hh Pathway. We then determined the genetic epistasis between aPKC and Hh signaling components, including Ptc and Smo. We found that inactivation of Ptc by RNAi caused anterior expansion of col-lacZ expression, which was blocked by aPKC RNAi (Fig. 3 A-C) , suggesting that aPKC acts downstream of Ptc. Interestingly, the levels of aPKC were elevated in ptc mutant cells of wing disc (Fig. 3D) , suggesting that aPKC could be regulated by Hh signaling (see below). The elevated Smo staining in ptc mutant clones indicated the relief of Ptc inhibition on Smo (Fig. 3D) . We also overexpressed aPKC ΔN with MS1096 Gal4 in wing disc that contained smo mutant clones. Interestingly, the elevated Ci was diminished (Fig. 3E ) and the expression of ptcLacZ at the A/P boundary was blocked (Fig. 3F) (20) . However, the kinases responsible for Ser680 and Ser683 phosphorylation are unknown (Fig. 4A ). Ser680 is a predicted PKC site, and Ser683 may be phosphorylated by either CK1 or GSK3, depending on the priming phosphoresidue. To determine the kinases involved in phosphorylating Ser680 and Ser683, we performed in vitro kinase assays using Smo656-755 purified by thrombin cleavage from GST-Smo fusion proteins. We found that Smo656-755 was phosphorylated by recombinant PKCζ, and the phosphorylation was enhanced by the addition of CK1 kinase (Fig. 4B, Upper) . PKC inhibitor completely blocked, whereas the CK1 inhibitor CK1-7 partially blocked, the phosphorylation by two kinases , which have a mutation at Ser680 and Ser683, respectively. The results showed that Ser683 was phosphorylated by CK1 when Ser680 was phosphorylated by recombinant PKCζ (Fig. 4B , Lower, lane 4), suggesting that Ser680 and Ser683 are likely PKC and CK1 sites, respectively. In addition, loss of shaggy (sgg) gene function resulted in accumulation of high levels of Ci (36, 37) but did not change Hh-induced Smo accumulation in wing disc (Fig. S1B) , indicating that Sgg/GSK3 does not regulate Smo accumulation in wing disc, and therefore that Ser683 is unlikely to be a GSK3 site.
To examine whether aPKC phosphorylates Smo in cultured cells, we transfected Myc-Smo WT into S2 cells and treated cells with Hh-conditioned medium, together with aPKC dsRNA or GFP dsRNA. Hh induced slow-migration hyperphosphorylated forms of Myc-Smo, indicative of Smo phosphorylation (Fig. 4C , Upper, lane 2 compared with lane 1). We found that the Hhinduced Smo mobility shift was attenuated by aPKC RNAi but not by GFP RNAi (Fig. 4C , Upper, lanes 4 and 5), indicating that Smo phosphorylation was regulated by aPKC. RNAi of aPKC did not cause any change in Smo in the absence of Hh (Fig. 4C , Upper, lane 3 compared with lane 1). We further verified phosphorylation changes in Smo using the Phos-tag gel that specifically retards phosphorylated proteins (33, 38) . We found that inactivation of aPKC by RNAi attenuated the phosphorylation of Smo, as indicated by the reduced mobility shift (Fig. 4C , Lower, and the corresponding densitometry graph on the right). dicating that mutating Ser680 and Ser683 attenuated Smo phosphorylation. This observation was confirmed by changes in mobility shifts of Myc-Smo on the Phos-tag gel (Fig. 4D, Lower) .
To test the functional effect of phosphorylation in vivo, we constructed Smo phosphomimetic or phosphodeficient mutants at Ser680 and Ser683. Smo transgenes were generated at a Cell extracts were immunoprecipitated with the anti-Myc antibody, followed by Western blotting with the anti-Myc antibody to examine the mobility shift of the protein on regular gel (Upper) or on a Phos-tag gel (Lower). GFP served as a transfection and loading control. (E) WT wing was immunostained to show dpp-lacZ expression at the A/P boundary. (F-O) Wing discs expressing the indicated constructs at the VK5-attP locus by MS1096 Gal4 were stained for dpp-lacZ. Arrows in F and G indicate the ectopic dpp-lacZ expression induced by the overexpression of Smo. (P-R) Wing discs expressing the indicated constructs by MS1096 Gal4 were stained for En. (S) Activity of each individual construct was assayed by the ptc-luc reporter using S2 cells cotransfected with tub-Ci. specific gemonic locus to ensure the same level of expression without positional effects (26 induced much higher levels of ectopic dpp-lacZ expression (Fig. 4J) , whereas expression of Smo 680-3SA had little, if any, activity (Fig. 4I ). These data suggest that phosphorylation at Ser680 and Ser683 promotes Smo activation.
Hh gradients promote Smo differential phosphorylation in a dose-dependent manner, and among the three PKA and CK1 phosphorylation clusters, phosphorylation of the membrane proximal cluster is more critical than phosphorylation of the distal cluster (26) . In this study, we found that mutating the PKA site of the second cluster in Smo 680-3SD (Smo 680-3SD-PKA2 ; Fig. 4A ) blocked the ectopic activity ( Fig. 4K compared with Smo 680-3SD in Fig. 4J ). In addition, Smo DAD , in which PKA and CK1 sites in the second cluster are mutated to Ala (Fig. 4A) , barely had any ectopic activity even though the first and third clusters have S>D mutations (26) (Fig. 4L) . Smo DAD680-3SD did not have any ectopic activity either (Fig. 4M) . In contrast, Smo , keeping the second cluster as WT, induced potent dpp-lacZ expression ( Fig.  4O compared with Fig. 4N ). Phosphomimetic mutation at the three clusters (Smo DDD ) led to hyperactivation of Smo, which induced peak levels of Hh signaling activity indicated by potent en expression (22, 26) (Fig. 4P) . Furthermore, Smo DDD680-3SA and Smo , in which Ser680 and Ser683 were mutated either to Ala or Asp in the background of Smo DDD (Fig. 4A) , induced en expression at comparable levels to Smo DDD (Fig. 4 Q-R) . These data suggest that, phosphorylation at the second cluster of PKA/ CK1 sites is required for aPKC-mediated phosphorylation to activate Smo.
We also performed a ptc-luciferase (luc) reporter assay in S2 cells, which were more sensitive than the wing discs, to examine the activity of Smo mutants (26) . In this assay, we found that Smo 680SD has higher activity than Smo WT (Fig. 4S ). In addition, Smo , and Smo DDD680-3SD induced comparable ptc-luc activity in cultured cells (Fig. 4S) , which is consistent with the induced comparable levels of en expression in wing discs (Fig. 4 P-R) . Also consistent with the data from imaginal discs, Smo 680-3SD-PKA2 had much lower luciferase activity compared with Smo
680-3SD
, and Smo DAD680-3SD had much lower luciferase activity compared with Smo DSD680-3SD (Fig. 4S) , confirming that phosphorylation at the second cluster of PKA/CK1 sites is required for aPKC to activate Smo.
Additional Role of aPKC in Hh Signaling. Overexpression of aPKC ΔN caused Ci elevation (Fig. 1H) , which was blocked by mutating smo (Fig. 3E) , suggesting aPKC requires Smo to promote Hh signaling. Surprisingly, knockdown of aPKC by RNAi attenuated the ectopic dpp-lacZ expression induced by Smo 680-3SD ( Fig. 5 A and B) . In addition, aPKC RNAi attenuated the activity of the superactive form of Smo, Smo DDD680-3SD ( Fig. 5E compared with Fig. 5D ). One possibility is that aPKC may phosphorylate Smo at additional residues. However, phosphomimetic or phosphodeficient mutation of other predicted PKC sites in the C terminus of Smo (including Ser885, Ser888, Ser890, Ser893, Ser957, and Thr1020) did not change the activity of Smo in wing discs. Another possibility is that aPKC regulates Smo through an additional role beyond phosphorylation, or through regulating Hh signaling component(s) downstream of Smo. In support of this hypothesis, we found that aPKC RNAi suppressed the activity of Ci −3P , in which three PKA sites in the phosphorylation clusters were mutated resulting in an active form of Ci (39) (Fig. 5 F and G) .
To determine further how aPKC regulates the activity of Ci, we examined whether aPKC regulates Ci through phosphorylating its DNA-binding domain, as is the case for the regulation of Gli1 by aPKC (40) . The expression of Ci-GA2, the Zn finger Ci DNA-binding domain (CiDB) fused to the Gal4 activation domain (41) , induced ptc-lacZ expression mostly in P compartment cells (Fig. 5H) . We found that Ci-GA2-induced ptc-lacZ expression was inhibited by RNAi of aPKC (Fig. 5I) . In contrast, Ci-GA2 activity was enhanced by coexpression of aPKC CAAX , as indicated by the ectopic ptc-lacZ expression in A compartment cells (Fig. 5J) . Sequencing analysis identified Thr512 and Thr590 in the Zn finger domain, which match the phosphorylation consensus sites for PKA and aPKC (Fig. 5O) . However, coexpression of MC*, the constitutively active form of PKA, did not change the activity of Ci-GA2 (Fig. 5K) , suggesting that these residues are likely to be aPKC sites. Thr512 and Thr590 were then mutated either alone or together in the background of Ci-GA2. We found that single mutations severely reduced the activity of Ci-GA2 (Fig. 5 L and M) and double mutations completely blocked the ability of Ci-GA2 to induce ptc-lacZ expression in P compartment cells (Fig. 5N) . Consistently, RNAi of aPKC decreased, whereas overexpression of aPKC CAAX increased, Ci-GA2 activity in a ptc-luc reporter assay (Fig. 5R) . Mutating Thr512 alone (Ci-GA2 TA1 ) attenuated its regulation by aPKC, and mutating both Thr512 and Thr590 (Ci-GA2 TA12 ) further blocked its regulation by aPKC (Fig.  5R) . We also found that mutating Thr512 and Thr590 in full-length Ci blocked its regulation by aPKC in the ptc-luc assay (Fig. 5S ). These observations suggest that aPKC regulates the activity of Ci in both wing discs and cultured S2 cells, likely through two critical residues: Thr512 and Thr590.
We wondered whether aPKC phosphorylates Ci directly, and thus performed an in vitro kinase assay using a purified Ci fragment (amino acids 497-604, cleaved from GST-Ci fusion protein) and recombinant aPKC. We found that aPKC was able to phosphorylate wild type Ci (Ci WT ) but not mutant Ci carrying the T512, 590A substitution (Ci TA12 ) (Fig. 5P) , indicating that aPKC phosphorylates these Thr residues. Because Thr512 and Thr590 fall into the DNA-binding domain and mutating these residues abolishes activity of Ci, we further tested whether phosphorylation promotes the ability of Ci to bind DNA. We carried out an EMSA to examine the interaction between DNA and Ci WT or mutant CiDB (amino acids 497-604) after in vitro phosphorylation by PKC. We found that CiDB WT did not bind DNA (Fig.  5Q, lane 2) , unless it was phosphorylated by PKC (lane 3). Blocking PKC activity by inhibitor prevented CiDB-DNA binding (Fig. 5Q, lane 4) . We further found that CiDB TA12 did not have the ability to bind DNA even though PKC was added to the assay (Fig. 5Q, lanes 5 and 6) . Taken together, our data suggest that aPKC positively regulates Ci activity by phosphorylating Ci at Thr512 and Thr590 and promoting Ci to bind DNA.
aPKC-Par6 Protein Complex Regulates Hh Signaling in Vivo.
It is also possible that the polarity protein complexes regulate Hh signaling through regulating cell polarity. It has been shown that aPKC forms a functional complex with Par6 to control epithelial polarization (12) . Indeed, the interaction between the endogenous aPKC and Par6 was readily detected in cultured S2 cells (Fig.  S2A) . Knockdown of aPKC by RNAi decreased, whereas overexpression of aPKC increased, the level of Par6 (Fig. S2B) . Additionally, in wing imaginal discs, aPKC RNAi decreased the level of Par6 and Par6 RNAi decreased the level of aPKC (Fig. S2 C  and D) . These data suggest that aPKC and Par6 may function as a stable complex to regulate Smo. Strikingly, basal accumulation of Smo in wing disc was blocked in cells with mutated par6 (Fig.  6A) . Similarly, knockdown of Par6 by RNAi attenuated Smo accumulation and down-regulated ptc-lacZ expression (Fig. 6 B and  C) . Overexpressing Par6 alone in wing disc neither caused Smo accumulation nor induced Ci elevation (Fig. 6D) . However, coexpressing Par6 with aPKC CAAX induced peak activation of Hh signaling, leading the A compartment cells to occupy the entire wing disc (Fig. 6E) and inducing overgrowth of the wing (Fig.  S2E) , whereas expressing aPKC CAAX alone induced a much lower level of ectopic Hh activity (Fig. 1G) . These findings suggest that aPKC and Par6 act together to regulate Hh signaling.
If the aPKC-Par6 protein complex regulates Hh signaling through controlling epithelial polarization, we reasoned that other polarity proteins necessary for the aPKC-Par6 complex should also be required. However, inactivation of Baz by either mutation or RNAi did not regulate Smo and Ci accumulation in wing discs (Fig. S3 A and B) . Similarly, inactivation of Crb, Dlg5, Dlg1, and Lgl by RNAi did not cause any changes in Smo and Ci accumulation (Fig. S3 D, E, and G) . Overexpression of either Baz or Dlg5 had no effect on Hh signaling (Fig. S3C) . These findings suggest that aPKC and Par6 are directly involved in Hh signaling, which may not require the other polarity proteins.
Hh Signaling Up-Regulates the Expression of aPKC. The elevated immunostaining of aPKC in ptc mutant cells suggests that Hh signaling may regulate aPKC expression (Fig. 3D) . The Drosophila wing/wing imaginal disc has been a classic organ used to dissect the mechanisms of Hh signal transduction. The transcription factor Ci is only expressed in the A compartment Hh receiving cells, so the behavior of cells in the A compartment near the A/P boundary has been well characterized. When we examined the expression pattern of endogenous aPKC in wing disc, we found that aPKC levels had mild elevation in A compartment cells near the A/P boundary where Hh receiving cells resided (Fig. 7A) , suggesting that Hh may elevate the levels of aPKC in the wing. To verify this notion further, we expressed Hh with the MS1096 Gal4 in wing discs and found elevation of aPKC in A compartment cells away from the A/P boundary, indicating the stabilization of aPKC by Hh expression (Fig. 7B) . Furthermore, the elevation of aPKC is likely Ci-dependent, because immunostaining of aPKC was only elevated in A compartment cells that express Ci. In support of this hypothesis, we found that the expression of aPKC was increased in both A and P compartment cells when Ci −3P was expressed (Fig. 7C) , and that the expression of aPKC was only elevated in A compartment cells when Smo DDD was expressed (Fig. 7D ). Our findings indicate that Hh induces the expression of aPKC, which phosphorylates and activates Smo and Ci, suggesting a positive feedback regulation of Hh signaling components by aPKC (Fig. 7E) . P]ATP-labeled oligos that contain the Ci/Gli-binding nucleotides, followed by native polyacrylamide gel separation and autoradiography. In this assay, Ci proteins containing amino acids 497-604 were bacterially expressed, dephosphorylated with calf intestinal alkaline phosphatase, and cleaved with thrombin (Experimental Procedures). The same amount of Ci fragment was used, and the experiment was repeated three times. Control, Ci WT with unlabeled oligos. (R) Activity of each Ci-GA2 construct containing the Zn finger DNAbinding domain fused to the Gal4 activation domain was examined using the ptc-luc reporter assay. (S) Activity of the indicated Ci full-length constructs was examined using the ptc-luc reporter assay. The y axis represents normalized ptc-luc activity.
Discussion
It has been shown that Hh protein can travel both apically and basally in cells near the A/P boundary but can only accumulate apically in cells away from the A/P boundary (42) , which may guide the accumulation of Smo in apical and basolateral domains in Drosophila wing disc (43) . However, it is unknown how Smo accumulation is controlled within the apical and basal domains of the wing and whether apical/basal polarity proteins are involved in the signal transduction. This study identifies aPKC as a positive regulator for Hh signal transduction by regulating both Smo and Ci. Importantly, we discover that aPKC has direct roles in Hh signaling by phosphorylating multiple Hh signaling components. Smo phosphorylation by aPKC at Ser680 promotes Smo activation. aPKC promotes the DNA-binding activity of Ci Zn finger DNA-binding domain through phosphorylating Thr512 and Thr590. These findings indicate that aPKC is directly involved in Hh signaling.
We found that phosphodeficient mutation in the second cluster of PKA/CK1 sites blocked the ectopic Smo activity (Fig. 4 J and  K) even if the aPKC site (amino acid 680) and adjacent CK1 site (amino acid 683) are mutated to Asp to mimic phosphorylation. It is possible that the main role of phosphorylation by aPKC at S680 and subsequent phosphorylation by CK1 is to promote PKA/CK1-mediated phosphorylation at the second cluster, or even the third cluster, according to the zipper-lock model we previously described (26) , which may account, at least in part, for the ability of aPKC to promote Smo activation. This finding can also explain why S680 phosphorylation is dispensable in Smo DDD background. It would be interesting to test this hypothesis in the future using phosphospecific antibodies to examine PKA/CK1-mediated phosphorylation at these individual sites in the presence or absence of aPKC-mediated phosphorylation at S680.
Both the loss and gain of aPKC studies indicate that aPKC promotes basolateral accumulation of Smo, which correlates with Hh pathway activation. The aPKC may regulate Smo subcellular localization by directly phosphorylating Smo at S680 and/or through other mechanisms. The examination of several polarity proteins, including Crb, Baz, Dlg5, Dlg1, and Lgl, showed that inactivation of these proteins produced polarity phenotypes but did not affect Smo accumulation and Hh signal transduction in Drosophila wings (Fig. S3) , suggesting that aPKC regulates the activity of Smo and Ci independent of its function in apical/basal polarity. However, we did observe that Smo accumulation and Hh signaling were affected by loss of Par6 function. Furthermore, coexpression of Par6 synergized with aPKC CAAX to promote Smo accumulation and Hh pathway activation. We found that Par6 and aPKC form a complex and that Par6 is required for aPKC stabilization, which may explain why Hh signaling is affected by loss of Par6. In addition to regulating aPKC stability, Par6 may facilitate aPKC to phosphorylate Smo and Ci, because an adaptor function of Par6 has been identified (44, 45) . Another possibility is that Par6 activates aPKC (46) , which, in turn, promotes Smo phosphorylation. It is also possible that Par6 has an additional function beyond coupling aPKC in regulating Smo activation because mutating par6 caused a more severe Smo reduction (Fig. 6A ) compared with the inactivation of aPKC (Fig. 2B) . Future study is needed to explore the precise mechanism by which the aPKCPar6 protein complex regulates Smo accumulation and Hh signal transduction.
Abnormal Smo activation has been found in BCC and medulloblastoma. In mammals, Hh induces Smo ciliary localization, and it has been speculated that dysregulation of Smo localization in the cilium will cause cancer. A recent study indicates that aPKC is accumulated in the cilia of BCC cells (40) . In addition, this study revealed that aPKC phosphorylates Gli1 to regulate its DNA-binding activity. Our study thus uncovers a conserved role of aPKC in the regulation of Ci/Gli DNA-binding activity. In addition, we find that the aPKC-Par6 complex regulates Smo subcellular localization. Given the interesting parallel between membrane accumulation of Smo in Drosophila and translocation of Smo to cilium in mammalian cells, it is possible that malfunction of aPKC will lead to aberrant Smo ciliary localization and activation, and thus cancer formation. Further investigation of whether Smo ciliary localization is regulated by aPKC will provide mechanistic insight into Smo-dependent tumorigenesis. The direct roles of the aPKC-Par6 complex in regulating Hh signaling components discovered in this study also raise the possibility that mammalian aPKC could regulate Hh signaling during embryonic development. attP locus (resulting in VK5 lines) by PhiC31 integration have been described previously (26, 47) . Smo variants with mutations in the aPKC and CK1 sites were generated by site-directed mutagenesis, and their transgenes were generated by the same approach. HA-Ci-GA2 RNAi lines were obtained from the VDRC (v108560, v19730, and v19731) and BSC (35000), and line v108560 was used for most of the experiments because all those lines gave rise to similar phenotypes. Cell Culture, Transfection, Western Blot, and Luciferase Reporter Assay. S2 cells were cultured as previously described (26) . Briefly, transfections were carried out using Effectene transfection reagent (Qiagen). Forty-eight hours posttransfection, cells were harvested and treated with lysis buffer [100 mM NaCl, 50 mM Tris·HCl (pH 8.0), 1.5 mM EDTA, 10% (vol/vol) glycerol, 1% (vol/vol) Nonidet P-40, and protease inhibitor tablet (Roche)]. Cell lysate was obtained by centrifuging at 13,200 × g for 10 min. A total of 6 × 10 6 cells were harvested and lysed in 450 μL of lysate buffer. Fifty microliters was saved for direct Western blots, of which 4 μL was used for each load. The remaining 400 μL was used for immunoprecipitation assay, in which cell lysate was added with beads of Protein A Ultralink Resin (Thermo Scientific) after adding the proper primary antibody for 2 h. The samples were then resolved by SDS/PAGE and transferred onto PVDF membranes (Millipore) for Western blotting. Western blot analysis was performed using the indicated antibodies and the ECL protocol. The use of Hh-conditioned medium has been described previously (26) . Treating S2 cells with OA or dsRNA has been described previously (26, 47) . The aPKC dsRNA was synthesized against ORF nucleotides 379-930. Antibodies used for Western blotting are as follows: mouse anti-HA (F7, 1:5,000; Santa Cruz Biotechnology), anti-β-tubulin (concentrated, 1:5,000; Developmental Studies Hybridoma Bank); rabbit anti-PKC (sc-216, 1:10,000; Santa Cruz Biotechnology), and anti-Par6 (1:5,000; a gift from Denise Montell). The ptc-luc reporter assay has been described with S2 cells transfected with tub-Ci (26).
Experimental Procedures
The Phos-tag gel assay was carried out as described previously (33) . Briefly, 20 μM Phos-tag acrylamide (AAL-107; Wako Chemical) and 40 μM MnCl 2 were included. Before electroblotting, the gels were soaked in transfer buffer containing 2 mM EDTA for 15 min to eliminate the manganese ion, followed by soaking in transfer buffer without EDTA for 15 min with gentle agitation. The duration of electroblotting was extended to 3 h. Densitometric analysis of Myc-Smo bands on the Phos-tag gels was done using ImageJ software (NIH, version 1.48).
In Vitro Kinase Assay, EMSA Assay, and Immunostaining of Wing Imaginal Discs. For the in vitro kinase assay, GST-Smo fusion proteins were expressed in bacteria, purified with GST beads, and cleaved with thrombin according to the manufacturer's instructions (GE Healthcare Life Science). Three micrograms of Smo was incubated at 30°C for 30 min in 50 μL of assay buffer containing 35 mM Tris (pH 7.5), 10 mM MgCl 2 , 0.1 mM CaCl 2 , 0.5 mM EGTA, and 2.5 μM ATP or 10 μCi of γ-[ 32 P]ATP in the presence of commercial recombinant human PKCζ (CD BioSciences) and CK1 (New England Biolabs), followed by autoradiography. Inhibitors used are as follows: myristoylated PKCζ pseudosubstrate inhibitor (10 μM, catalog no. 539624; Millipore) and CK1-7 dihydrochloride (10 μM, catalog no. 1177141-67-1; Sigma-Aldrich) (22) . GST-Ci WT and GST-Ci TA12 containing Ci amino acids 497-604 with either WT or Thr512/Thr590 mutated to Ala were expressed in bacteria, purified with GST beads, cleaved with thrombin, and subjected to the in vitro kinase assay with the same methods as used for Smo. To ensure an equal amount of Ci fragment in each reaction, the same amount of GST-Ci protein was used to achieve Ci fragmentation, with the same conditions for cleavage.
For the EMSA DNA-binding assay, GST-Ci proteins were bacterially expressed; purified using the method described above; dephosphorylated with calf intestinal alkaline phosphatase (catalog no. 10713023001; Roche) in 50 μL of buffer containing 50 mM Tris·HCl (pH 7.9), 10 mM MgCl 2 , 100 mM NaCl 2 , 1 mM DTT, and protease inhibitor at 37°C for 60 min; and finally cleaved with thrombin. The DNA probe containing the Ci/Gli-binding site was generated by annealing two oligos and labeled with γ-[ 32 P]ATP by Klenow fragment (Roche). The oligos were CiBS1 (5′-CACTGAGAT TGGGTGGTC TATCAGTT-3′) and CiBS2 (5′-AACTGATA GACCACCCA ATCTCAGTG-3′), with the 9-bp core consensus Ci/Gli-binding site underlined (50) . For each reaction, 20 μL of incubation buffer was used, which contained 15 mM Hepes (pH 7.9), 80 mM NaCl, 15 mM KCl, 20 μM EDTA, 1 mM DTT, 3% glycerol, and 1 μM probe. PKCζ and PKCζ pseudosubstrate inhibitor were added if necessary. Samples were separated with 8% (vol/vol) native polyacrylamide gel in TBE (Tris/ Borate/EDTA, a buffer solution containing a mixture of Tris base, boric acid and EDTA), followed by autoradiography.
For imaginal disc immunostaining, wing discs from third instar larvae with specific genotypes were dissected in PBS and then fixed with 4% (vol/vol) formaldehyde in PBS for 20 min. After permeabilization with PBT (PBS supplemented with 1% Triton X100), discs were incubated with the indicated primary antibodies for 3 h and the corresponding secondary antibodies for 1 h sequentially, and then washed with PBT three times, for 20 min per wash, following incubations. Antibodies used in this study are as follows: mouse anti-SmoN (1:10; Developmental Studies Hybridoma Bank), anti-Ptc (1:10;
Developmental Studies Hybridoma Bank), anti-Myc (9E10, 1:50; Santa Cruz Biotechnology), anti-En (1:20; Developmental Studies Hybridoma Bank), rabbit anti-PKC (sc-216, 1:1,000; Santa Cruz Biotechnology), anti-Par6 (1:500; a gift from Denise Montell), anti-β-gal (1:1,500; Cappel), and rat anti-Ci (2A, 1:10; Developmental Studies Hybridoma Bank). 
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